SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : T/FIF, a New Plateau

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tuck who wrote (755)11/27/2001 1:03:39 PM
From: scaram(o)uche  Read Replies (2) of 2243
 
Yeah, being cash-strapped is tough. Lots of large shareholders who could want to lighten up? Please let me know when it's time to buy it, and I'll sell something if I don't have cash.

The portions that you highlighted with bold had no special meaning to me, other than that they had shown a molecular ass'n between SLAP-2 and a ubiquitin ligase. Was there a meaning inherent in the bolding?

Ubiquitin ligases...... I don't know much about them. If there are different ligases for regulatory proteins like CDKs (take note, apostrophe police!!), then it might make sense. If not, it seems like just another anti-cancer approach that will land us in "selective toxicity" land. If anyone runs across any preclinical (mouse, etc.) data, please yell!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext